APA

Lal D., Park J. A., Demock K., Marinaro J., Perez A. M., Lin M., Tian L., Mashtare T. J., Murphy M., Prey J., Wetzler M., Fetterly G. J. & Wang E. S. (20110310). Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models. : Molecular cancer therapeutics.

Chicago

Lal Deepika, Park Jennifer A, Demock Kellie, Marinaro Joseph, Perez Amanda M, Lin Mei-Hui, Tian Lili, Mashtare Terry J, Murphy Michael, Prey Joshua, Wetzler Meir, Fetterly Gerald J and Wang Eunice S. 20110310. Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models. : Molecular cancer therapeutics.

Harvard

Lal D., Park J. A., Demock K., Marinaro J., Perez A. M., Lin M., Tian L., Mashtare T. J., Murphy M., Prey J., Wetzler M., Fetterly G. J. and Wang E. S. (20110310). Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models. : Molecular cancer therapeutics.

MLA

Lal Deepika, Park Jennifer A, Demock Kellie, Marinaro Joseph, Perez Amanda M, Lin Mei-Hui, Tian Lili, Mashtare Terry J, Murphy Michael, Prey Joshua, Wetzler Meir, Fetterly Gerald J and Wang Eunice S. Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models. : Molecular cancer therapeutics. 20110310.